Form 8-K - Current report:
SEC Accession No. 0001193125-24-263477
Filing Date
2024-11-21
Accepted
2024-11-21 16:55:29
Documents
21
Period of Report
2024-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d769920d8k.htm   iXBRL 8-K 39942
2 EX-1.1 d769920dex11.htm EX-1.1 187376
3 EX-4.1 d769920dex41.htm EX-4.1 62896
4 EX-4.2 d769920dex42.htm EX-4.2 79713
5 EX-4.3 d769920dex43.htm EX-4.3 80334
6 EX-5.1 d769920dex51.htm EX-5.1 15285
7 EX-99.1 d769920dex991.htm EX-99.1 9592
11 GRAPHIC g769920dsp91.jpg GRAPHIC 4353
12 GRAPHIC g769920g1121123843854.jpg GRAPHIC 3481
  Complete submission text file 0001193125-24-263477.txt   739263

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA vrca-20241120.xsd EX-101.SCH 2851
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20241120_lab.xml EX-101.LAB 17995
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20241120_pre.xml EX-101.PRE 11262
23 EXTRACTED XBRL INSTANCE DOCUMENT d769920d8k_htm.xml XML 3618
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 241485229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)